Literature DB >> 12087668

[Dacryolithiasis--analysis of 15 cases].

P Komínek1, S Cervenka, S Doskárová, D Heiderová, D Slabík, P Husek, J Buryska.   

Abstract

Dacryoliths are found in 15-20% patients subject to dacryocystorhinostomy. Dacryoliths are formed by proteins or calcium and phosphate salts. In the development or dacryolithiasis participates chronic inflammation of the sac, it is found more frequently in women where some part is played by the structure of the lacrimal duct, hormonal influence and the use of cosmetic preparations. A typical sign of the disease in the variability of complaints and results of clinical examinations. Assessment of the diagnosis before surgery can be facilitated by dacryocystography. The method of choice in dacryolithiasis is dacryocystorhinostomy. The authors present their own group of 16 dacryolithis which they observed 10x in women and 5x men. The concrements were examined by the method of infrared spectroscopy and gas chromatography. All were formed by proteins; calcium and phosphate salts were not found In all patients after dacryocystorhinostomy the complaints disappeared.

Entities:  

Mesh:

Year:  2002        PMID: 12087668

Source DB:  PubMed          Journal:  Cesk Slov Oftalmol        ISSN: 1211-9059


  3 in total

1.  TFF peptides and mucins are major components of dacryoliths.

Authors:  Friedrich P Paulsen; Ulrich Schaudig; Alexander Fabian; Dirk Ehrich; Saadettin Sel
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2006-02-02       Impact factor: 3.117

2.  Lacrimal sac dacryoliths (86 samples): chemical and mineralogic analyses.

Authors:  Pavel Komínek; Sárka Doškářová; Zdeněk Svagera; Karel Lach; Stanislav Cervenka; Karol Zeleník; Petr Matoušek
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2013-10-30       Impact factor: 3.117

3.  [Concretions and iatrogenic foreign bodies in the lacrimal system : Treatment recommendations].

Authors:  J Heichel; A Sandner; U Siebolts; D Bethmann; H-G Struck
Journal:  HNO       Date:  2016-06       Impact factor: 1.284

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.